Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver fibrosis severity evaluated by shear-wave elastography is associated with procoagulant and systemic inflammatory activity in patients with cirrhosis.

Annals of gastroenterology·2026
Same author

Enhancing the Therapeutic Profile of Dapagliflozin: Chitosan Nanoparticle Encapsulation for Intestinal Applications.

FASEB bioAdvances·2026
Same author

The Use of EEG in the Study of Emotional States and Visual Word Recognition with or Without Musical Stimulus in University Students with Dyslexia.

Brain sciences·2026
Same author

Clinical, Cognitive and Demographic Determinants of Work Participation in Multiple Sclerosis: A Multicenter Cross-Sectional Study.

Medicina (Kaunas, Lithuania)·2026
Same author

Development and validation of a risk score for transthyretin amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: the GRECA-TAVI registry.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2026
Same author

Circulating Humanin Improves the Prognostic Accuracy of Cardiovascular Risk Models in Chronic Hemodialysis Patients.

Cardiorenal medicine·2026

Related Experiment Video

Updated: Jan 11, 2026

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies
08:16

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies

Published on: November 5, 2016

8.1K

Revolutionizing Heart Valve Therapy: A Translational Framework for Combining Decellularized Scaffolds With Genetic

Nikolaos P Tzavellas1, Natalia Atzemoglou1, Efstathios L Pavlidis1

  • 1Department of Physiology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.

Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|November 11, 2025
PubMed
Summary
This summary is machine-generated.

Gene editing combined with decellularized scaffolds offers new hope for treating valvular heart disease. This approach aims to create durable, biocompatible heart valves, especially benefiting younger patients needing long-term solutions.

Keywords:
CRISPR‐Cas9decellularized scaffoldsgene editing techniquesvalvular heart disease

More Related Videos

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
10:56

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation

Published on: July 23, 2014

19.3K
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.5K

Related Experiment Videos

Last Updated: Jan 11, 2026

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies
08:16

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies

Published on: November 5, 2016

8.1K
Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
10:56

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation

Published on: July 23, 2014

19.3K
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.5K

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Gene Editing Technologies

Background:

  • Valvular heart disease (VHD) affects over 2.5% of the population, with current treatments like mechanical and bioprosthetic valves having significant limitations.
  • Mechanical valves necessitate lifelong anticoagulation, increasing bleeding risks, while bioprosthetic valves have limited durability (10-15 years).
  • These limitations are especially challenging for pediatric and young adult patients requiring multiple surgeries throughout their lives.

Purpose of the Study:

  • To explore the potential of combining decellularized scaffolds with gene editing technologies for improved heart valve replacement.
  • To address the biological challenges of decellularized scaffolds, such as poor recellularization, inflammation, and calcification.
  • To propose pathways for translating these integrated technologies into clinical practice for enhanced VHD treatment.

Main Methods:

  • Review of current literature on decellularized scaffolds for tissue engineering heart valves.
  • Analysis of recent advances in gene editing technologies (CRISPR-Cas9, base editing) for molecular tissue modification.
  • Exploration of the synergistic potential of integrating gene editing with decellularized scaffolds.

Main Results:

  • Decellularized scaffolds offer a natural extracellular matrix but face challenges like suboptimal recellularization and degradation.
  • Gene editing technologies enable precise modifications to enhance scaffold biocompatibility and cellular response.
  • The combination approach shows promise for creating more durable and biocompatible valve replacements.

Conclusions:

  • Integrating gene editing with decellularized scaffolds could overcome current limitations in heart valve replacement therapy.
  • This innovative approach may lead to the development of heart valves with improved durability and biocompatibility.
  • The technology holds particular promise for pediatric and young adult patients, offering valves capable of growth and long-term function, reducing the need for repeat surgeries.